Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
- Resource Type
- Academic Journal
- Source
Advances in Therapy (ADV THER), Mar2024; 41(3): 901-914. (14p)- Subject
- Language
- English
- ISSN
- 0741-238X